Skip to content
  • Twitter
  • Facebook
  • DMCA
  • Privacy Policy
  • Terms of Use
Market Newswire

Market Newswire

The Latest Press Releases

  • Business Wire
  • PR Newswire
  • Globe Newswire
  • OpenPR
  • IssueWire
  • US Newswire
  • SEC Filings
  • Toggle search form

Azenta to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit

Posted on August 5, 2022 By News Desk

Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the UBS Genomics 2.0 and MedTech Innovations Summit in Dana Point, CA, on Thursday, August 11, 2022, which includes a presentation beginning at 4:00 pm PT. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event. About Azenta Life Sciences Azenta, Inc. (Nasdaq: AZTA) is a leading provid(…..) Continue reading ยป

PR Newswire

Post navigation

Previous Post: ICF to Present at the Canaccord Genuity 42nd Annual Growth Conference
Next Post: 8-K Reg FD – Core Scientific, Inc./tx (0001839341) August 05

Archives

  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021

Categories

  • Business Wire
  • Globe Newswire
  • IssueWire
  • OpenPR
  • PR Newswire
  • SEC Filings
  • Uncategorized
  • US Newswire

Recent Posts

  • Phosphate Rocks Market is projected to show a valuation of more than US$ 23 Bn by the end of 2022
  • Masterbatches Market is expected to expand at US$ 50.79 Bn in 2025
  • Liquid Masterbatches Market is slated to touch a value of about US$ 11,600 Mn in the year 2022
  • BIGZ INVESTOR ALERT: Did You Sustain Losses? Contact National Securities Law Firm Klaymantoskes
  • Global DC Brushless Fans Market Driven by Increasing Urbanization in Emerging Economies: Ken Research

Copyright © 2022 Market Newswire.

Powered by PressBook WordPress theme

Go to mobile version